Literature DB >> 20070948

Four distinct structural domains in Clostridium difficile toxin B visualized using SAXS.

David Albesa-Jové1, Thomas Bertrand, Elisabeth P Carpenter, Gemma V Swain, Jenson Lim, Jiancheng Zhang, Lesley F Haire, Nishi Vasisht, Veit Braun, Anton Lange, Christoph von Eichel-Streiber, Dmitri I Svergun, Neil F Fairweather, Katherine A Brown.   

Abstract

Clostridium difficile is a nosocomial bacterial pathogen causing antibiotic-associated diarrhea and fatal pseudomembranous colitis. Key virulence factors are toxin A and toxin B (TcdB), two highly related toxins that are members of the large clostridial toxin family. These large multifunctional proteins disrupt cell function using a glucosyltransferase domain that is translocated into the cytosol after vesicular internalization of intact holotoxin. Although substantial information about the biochemical mechanisms of intoxication exists, research has been hampered by limited structural information, particularly of intact holotoxin. Here, we used small-angle X-ray scattering (SAXS) methods to obtain an ab initio low-resolution structure of native TcdB, which demonstrated that this molecule is monomeric in solution and possesses a highly asymmetric shape with a maximum dimension of approximately 275 A. Combining this SAXS information with crystallographic or modeled structures of individual functional domains of TcdB reveals for the first time that the three-dimensional structure of TcdB is organized into four distinct structural domains. Structures of the N-terminal glucosyltransferase, the cysteine protease, and the C-terminal repeat region can be aligned within three domains of the SAXS envelope. A fourth domain, predicted to be involved in the translocation of the glucosyltransferase, appears as a large solvent-exposed protrusion. Knowledge of the shapes and relative orientations of toxin domains provides new insight into defining functional domain boundaries and provides a framework for understanding how potential intra-domain interactions enable conformational changes to propagate between domains to facilitate intoxication processes. Copyright (c) 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20070948     DOI: 10.1016/j.jmb.2010.01.012

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  27 in total

1.  Structural organization of the functional domains of Clostridium difficile toxins A and B.

Authors:  Rory N Pruitt; Melissa G Chambers; Kenneth K-S Ng; Melanie D Ohi; D Borden Lacy
Journal:  Proc Natl Acad Sci U S A       Date:  2010-07-12       Impact factor: 11.205

2.  Deletion of a 19-Amino-Acid Region in Clostridioides difficile TcdB2 Results in Spontaneous Autoprocessing and Reduced Cell Binding and Provides a Nontoxic Immunogen for Vaccination.

Authors:  Sarah J Bland; Jason L Larabee; Tyler M Shadid; Mark L Lang; Jimmy D Ballard
Journal:  Infect Immun       Date:  2019-07-23       Impact factor: 3.441

3.  Masking autoprocessing of Clostridium difficile toxin A by the C-terminus combined repetitive oligo peptides.

Authors:  Yongrong Zhang; Therwa Hamza; Si Gao; Hanping Feng
Journal:  Biochem Biophys Res Commun       Date:  2015-02-26       Impact factor: 3.575

4.  Critical roles of Clostridium difficile toxin B enzymatic activities in pathogenesis.

Authors:  Shan Li; Lianfa Shi; Zhiyong Yang; Yongrong Zhang; Gregorio Perez-Cordon; Tuxiong Huang; Jeremy Ramsey; Numan Oezguen; Tor C Savidge; Hanping Feng
Journal:  Infect Immun       Date:  2014-11-17       Impact factor: 3.441

5.  Cytotoxicity of Clostridium difficile toxin B does not require cysteine protease-mediated autocleavage and release of the glucosyltransferase domain into the host cell cytosol.

Authors:  Shan Li; Lianfa Shi; Zhiyong Yang; Hanping Feng
Journal:  Pathog Dis       Date:  2013-01-14       Impact factor: 3.166

6.  Protective antibody responses against Clostridium difficile elicited by a DNA vaccine expressing the enzymatic domain of toxin B.

Authors:  Ke Jin; Shixia Wang; Chunhua Zhang; Yanling Xiao; Shan Lu; Zuhu Huang
Journal:  Hum Vaccin Immunother       Date:  2012-11-10       Impact factor: 3.452

7.  Structural basis for antibody recognition in the receptor-binding domains of toxins A and B from Clostridium difficile.

Authors:  Tomohiko Murase; Luiz Eugenio; Melissa Schorr; Greg Hussack; Jamshid Tanha; Elena N Kitova; John S Klassen; Kenneth K S Ng
Journal:  J Biol Chem       Date:  2013-12-05       Impact factor: 5.157

Review 8.  Diagnosis of Clostridium difficile infection: an ongoing conundrum for clinicians and for clinical laboratories.

Authors:  Carey-Ann D Burnham; Karen C Carroll
Journal:  Clin Microbiol Rev       Date:  2013-07       Impact factor: 26.132

9.  Crystal structure of Clostridium difficile toxin A.

Authors:  Nicole M Chumbler; Stacey A Rutherford; Zhifen Zhang; Melissa A Farrow; John P Lisher; Erik Farquhar; David P Giedroc; Benjamin W Spiller; Roman A Melnyk; D Borden Lacy
Journal:  Nat Microbiol       Date:  2016-01-11       Impact factor: 17.745

10.  Variations in TcdB activity and the hypervirulence of emerging strains of Clostridium difficile.

Authors:  Jordi M Lanis; Soumitra Barua; Jimmy D Ballard
Journal:  PLoS Pathog       Date:  2010-08-19       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.